Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 55 REF: 4Z-N-066073	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 70 REF: 4Z-C-121073CAS: 868539-96-2	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 12 REF: 4Z-F-3134	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 13 REF: 4Z-E-068026	- - -	To inquire	Tue 10 Dec 24
Tamoxifen-d5 (Phenyl-ring-d5) REF: 4Z-T-0126	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 30 REF: 4Z-P-196034	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 36 REF: 4Z-E-068049CAS: 208122-06-9	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 18 (Intedanib Impurity 18) REF: 4Z-N-066032	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 26 REF: 4Z-B-119029	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 6 REF: 4Z-O-032008CAS: 179897-89-3	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 1 (Intedanib Impurity 1) REF: 4Z-N-066010CAS: 2514952-69-1	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 20 REF: 4Z-L-124025	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 25 REF: 4Z-C-121028CAS: 2049024-37-3	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 16 REF: 4Z-P-196020	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 54 REF: 4Z-E-068067	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 19 REF: 4Z-G-047024CAS: 147619-40-7	- - -	To inquire	Tue 10 Dec 24
Nintedanib N-Glucuronide-2 REF: 4Z-N-066037	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 47 REF: 4Z-C-121050CAS: 82732-07-8	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 45 REF: 4Z-E-068058CAS: 73792-08-2	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 30 REF: 4Z-L-124036CAS: 17609-80-2 52671-64-4	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 55

Ref: 4Z-N-066073

Carfilzomib Impurity 70

Ref: 4Z-C-121073

Fulvestrant Impurity 12

Ref: 4Z-F-3134

Enzalutamide Impurity 13

Ref: 4Z-E-068026

Tamoxifen-d5 (Phenyl-ring-d5)

Ref: 4Z-T-0126

Palbociclib Impurity 30

Ref: 4Z-P-196034

Enzalutamide Impurity 36

Ref: 4Z-E-068049

Nintedanib Impurity 18 (Intedanib Impurity 18)

Ref: 4Z-N-066032

Bestatin Impurity 26

Ref: 4Z-B-119029

Olaparib Impurity 6

Ref: 4Z-O-032008

Nintedanib Impurity 1 (Intedanib Impurity 1)

Ref: 4Z-N-066010

Lenvatinib Impurity 20

Ref: 4Z-L-124025

Carfilzomib Impurity 25

Ref: 4Z-C-121028

Palbociclib Impurity 16

Ref: 4Z-P-196020

Enzalutamide Impurity 54

Ref: 4Z-E-068067

Gimeracil Impurity 19

Ref: 4Z-G-047024

Nintedanib N-Glucuronide-2

Ref: 4Z-N-066037

Carfilzomib Impurity 47

Ref: 4Z-C-121050

Enzalutamide Impurity 45

Ref: 4Z-E-068058

Lenvatinib Impurity 30

Ref: 4Z-L-124036